<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00212654</url>
  </required_header>
  <id_info>
    <org_study_id>ONO-1101-21</org_study_id>
    <nct_id>NCT00212654</nct_id>
  </id_info>
  <brief_title>Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan</brief_title>
  <official_title>Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ono Pharmaceutical Co. Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ono Pharmaceutical Co. Ltd</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative
      supraventricular tachyarrhythmias.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2001</start_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients who met the heart rate reduction criteria (20% reduction from the baseline heart rate and a heart rate of &lt;100 beats/min)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate, blood pressure, rate-pressure-product and ECG</measure>
  </secondary_outcome>
  <enrollment>165</enrollment>
  <condition>Postoperative Supraventricular Tachyarrythmia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ONO-1101</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 20 years or older

          2. Postoperative supraventricular tachyarrhythmias

          3. Within 7 days postoperatively

          4. Other inclusion criteria as specified in the protocol

        Exclusion Criteria:

          1. Acute myocardial infarction (within 1 month after onset)

          2. Severe heart failure [New York Heart Association (NYHA) functional class III or
             higher]

          3. Atrioventricular block (grade II or higher), or sick sinus syndrome

          4. Other exclusion criteria as specified in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Project Leader, Development Planning</last_name>
    <role>Study Director</role>
    <affiliation>Ono Pharmaceutical Co. Ltd</affiliation>
  </overall_official>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ONO-1101</keyword>
  <keyword>Landiolol Hydrochloride</keyword>
  <keyword>Postoperative</keyword>
  <keyword>supraventricular tachyarrhythmia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Landiolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

